Ophthalmology Doctors in Elgin, IL Accepting Medicare

7 Ophthalmology doctors found. Showing 1 - 7

Evelyn S Ackermann, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1670 Capital Street, Suite 100, Elgin, IL 60124 Phone: 847-888-2020    Fax: 847-888-0652

Dr. Sidney S Bernstein, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1670 Capital St, Suite 100, Elgin, IL 60124 Phone: 847-888-2020    Fax: 847-888-0652

Dr. Harry A. Bernstein, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2521 Technology Dr, Suite 202, Elgin, IL 60124 Phone: 847-836-1122    Fax: 847-836-1121

Michael L Seigle, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1670 Capital Street, Suite 100, Elgin, IL 60124 Phone: 847-888-2020    Fax: 847-888-0652

Mr. William M Reiff, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1435 N Randall Rd, Suite 102, Elgin, IL 60123 Phone: 847-841-8866    Fax: 847-841-8986

Dr. Rehan Mohammad Hussain, M.D, Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 1530 N Randall Rd Ste 202, Elgin, IL 60123 Phone: 847-488-1030    Fax: 847-488-0677

Dr. Rashmi Kapur, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1530 N Randall Rd Ste 202, Elgin, IL 60123 Phone: 847-488-1030    Fax: 847-488-0677

News Archive

Prasco to sell and distribute authorized generic version of ZEGERID capsules

Prasco Laboratories announced today that it is now shipping the authorized generic version of ZEGERID® (omeprazole/sodium bicarbonate) capsules. Authorized generics are generic pharmaceuticals manufactured identically to the brand product and sold under a private label. Under the terms of a distribution and supply agreement with Santarus, Prasco will sell and distribute the capsule form of Omeprazole/Sodium Bicarbonate in 20 mg and 40 mg strengths in the U.S. under the Prasco label.

Cortex area thinner in youth with Alzheimer's-related gene

A part of the brain first affected by Alzheimer's disease is thinner in youth with a risk gene for the disorder, a brain imaging study by researchers at the National Institute of Mental Health (NIMH), one of the National Institutes of Health, has found.

City of Hope receives $3.7 million from CIRM to develop phase 1 glioblastoma trial

The California Institute for Regenerative Medicine board has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients that will genetically engineer their stem cells to better tolerate chemotherapy's side effects, allowing them to receive higher doses of the therapy.

NHLBI stops enrollment in study comparing resuscitation strategies

Enrollment has ended early in a large, multicenter clinical trial comparing two distinct resuscitation strategies delivered by emergency medical service (EMS) providers to increase blood flow during cardiac arrest. The study's independent monitoring board and the National Heart, Lung, and Blood Institute (NHLBI), the lead sponsor of the study, stopped enrollment based on preliminary data suggesting that neither strategy significantly improved survival.

Read more Medical News

› Verified 2 days ago